Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography-chemical ionization-tandem mass spectrometry

使用气相色谱-化学电离-串联质谱法区分区域异构体氯苯丙胺类似物

阅读:4
作者:Shoko Negishi, Yukiko Nakazono, Yuko T Iwata, Tatsuyuki Kanamori, Kenji Tsujikawa, Kenji Kuwayama, Tadashi Yamamuro, Kazuna Miyamoto, Takuya Yamashita, Fumiyo Kasuya, Hiroyuki Inoue

Abstract

In recent years, a large number of clandestinely synthesized new psychoactive substances with high structural variety have been detected in forensic samples. Analytical differentiation of regioisomers is a significant issue in forensic drug analysis, because, in most cases, legal controls are placed on only one or two of the conceivable isomers. In this study, gas chromatography-tandem mass spectrometry (GC-MS-MS) was used to differentiate the regioisomers of chloroamphetamine analogs (chloroamphetamines and chloromethamphetamines) synthesized in the authors' laboratories. Free bases, trifluoroacetyl derivatives, and trimethylsilyl derivatives were subjected to GC-MS-MS using DB-1ms, DB-5ms, and DB-17ms capillary columns, respectively. The regioisomers of chloroamphetamine analogs in all forms were well separated on the DB-5ms column. The electron ionization mass spectra of the chloroamphetamine analogs gave very little structural information for differentiation among these analogs, even after trifluoroacetyl and trimethylsilyl derivatization of the analytes. Characteristic product ions of the 2-positional isomers were observed by electron ionization-MS-MS. In contrast, chemical ionization-MS-MS of the free bases provided more structural information about chloride position on the aromatic ring when [M+H-HCl]+ was selected as a precursor ion. The results suggest that a combination of chromatographic analysis and MS-MS supports differentiation for regioisomers of chloroamphetamine analogs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。